MMMaría José Mataró

María José Mataró

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


María José Mataró has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Outcomes of Isolated Tricuspid Valve Surgery

    by Gemma Sánchez-Espín, Jorge Rodríguez-Capitán, Juan José Otero Forero, Víctor Manuel Becerra Muñoz, Emiliano Andrés Rodríguez Caulo, Miguel Such-Martínez, Carlos Porras-Martín, José Manuel Villaescusa-Catalán, María José Mataró-López, Aranta Guzón-Rementería, et al.

    Background: Isolated tricuspid valve surgery is a rarely performed procedure and traditionally is associated with a bad prognosis, although its clinical outcomes still are little known. The aim of this study was to assess the short- and long-term clinical outcomes obtained at our center after isolated tricuspid valve surgery as treatment for severe tricuspid regurgitation. Methods: This retrospective study included 71 consecutive patients with severe tricuspid regurgitation who underwent isolated tricuspid valve surgery between December 1996 and December 2017. Perioperative and long-term mortality, tricuspid valve reoperation, and functional class were analyzed after follow up. Results: Regarding surgery, 7% of patients received a De Vega annuloplasty, 14.1% an annuloplasty ring, 11.3% a mechanical prosthesis, and 67.6% a biological prosthesis. Perioperative mortality was 12.7% and no variable was shown to be predictive of this event. After a median follow up of 45.5 months, long-term mortality was 36.6%, and the multivariate analysis identified atrial fibrillation as the only predictor (Hazard Ratio 3.014, 95% confidence interval 1.06-8.566; P = 0.038). At the end of follow up, 63.6% of survivors had functional class I. Conclusions: Isolated tricuspid valve surgery was infrequent in our center. Perioperative mortality was high, as was long-term mortality. However, a high percentage of survivors were barely symptomatic after follow up.


  • Open Access

    Mejora de la morbilidad postoperatoria en recambio valvular aórtico aislado con miniesternotomía: estudio pareado por puntuación de propensión

    by Emiliano A. Rodríguez-Caulo, Juan J. Otero Forero, María J. Mataró, Gemma Sánchez Espín, Carlos Porras, Arantza Guzón, Miguel Such, José M. Melero

  • Open Access

    Type 2 diabetes is associated with decreased PGC1α expression in epicardial adipose tissue of patients with coronary artery disease

    by Inmaculada Moreno-Santos, Luis Miguel Pérez-Belmonte, Manuel Macías-González, María José Mataró, Daniel Castellano, Miguel López-Garrido, Carlos Porras-Martín, Pedro L. Sánchez-Fernández, Juan José Gómez-Doblas, Fernando Cardona, et al.

    Although recent studies indicate that epicardial adipose tissue expresses brown fat-like genes, such as PGC1α, UCP1 and PRDM16, the association of these genes with type 2 diabetes mellitus (DM2) in coronary artery disease (CAD) remains unknown. PGC1α, UCP1, and PRDM16 mRNAs expression levels were measured by real-time PCR in epicardial and thoracic subcutaneous adipose tissue from 44 CAD patients (22 with DM2 [CAD-DM2] and 22 without DM2 [CAD-NDM2]) and 23 non-CAD patients (NCAD). The CAD-DM2 patients had significantly lower PGC1α and UCP1 expression in epicardial adipose tissue than the CAD-NDM2 and NCAD patients. However, PGC1α and UCP1 mRNA trended upward in subcutaneous adipose tissue from CAD-DM2 patients. At multiple regression analysis, age, body mass index, left ventricular ejection fraction, UCP1 expression of epicardial adipose tissue and diabetes came out to be independent predictors of PGC1α levels. Epicardial adipose tissue PGC1α expression was dependent on the number of injured coronary arteries and logistic regression analysis showed that PGC1α expression in epicardial adipose tissue could exert a protective effect against coronary lesions. DM2 is associated with decreased expression of PGC1α and UCP1 mRNA in epicardial adipose tissue of patients with CAD, likely reflecting a loss of brown-like fat features. Decreased expression of PGC1α in human epicardial adipose tissue is associated with higher prevalence of coronary lesions.


  • Minimally Invasive Approach for Valvular Surgery and Atrial Septal Defect

    by Gemma Sánchez-Espín, Juan J. Otero, Emiliano A. Rodríguez, María J. Mataró, Carlos Porras, José M. Melero

  • Coronary Bypass Grafting to a “Full-Metal Jacket” Left Anterior Descending Artery

    by María J. Mataró, Gemma Sánchez-Espín, Carlos Porras, José M. Melero, Eduardo Olalla, Miguel Such